Skip to main content

Table 2 Surgical treatments and outcomes, by group

From: Potential of the SPY intraoperative perfusion assessment system to reduce ischemic complications in immediate postmastectomy breast reconstruction

 

Pre-SPY

Post-SPY

P-value

Bilateral, N (%)

28 (53.8)

23 (59.0)

0.674†

Unilateral, N (%)

24 (46.2)

16 (41.0)

Implant, N (%)

49 (94.2)*

22 (56.4)

0.215†

Tissue expander, N (%)

22 (42.3)*

17 (43.6)

Implant size, mean cc (SD)

519.8 (164.7)

575.9 (140.5)

0.074**

Total complications, N (%)

19 (36.5)

7 (17.9)

0.0631†

Flap necrosis

9 (17.3)

4 (10.3)

 

Capsular contracture

5 (9.6)

0 (0.0)

 

Cellulitis

2 (3.8)

1 (2.6)

 

Hematoma

0 (0.0)

1 (2.6)

 

Extrusion of TE

1 (1.9)

0 (0.0)

 

Displacement of implant

1 (1.9)

0 (0.0)

 

Deflation of TE

1 (1.9)

0 (0.0)

 

Other

0 (0.0)

1 (2.6)‡

 

No. repeat OR visits, mean (SD)

1.21 (1.47)

0.41 (0.71)

0.0023**

  1. *Includes multiple repeat procedures for individual patients.
  2. **Unpaired t-test.
  3. †Fisher’s exact test.
  4. ‡One incidental suture spitting noted during port placement.
Back to article page

Annals of Surgical Innovation and Research

ISSN: 1750-1164

Contact us